Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001847903-25-000114
Filing Date
2025-06-25
Accepted
2025-06-25 19:43:37
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750895010.html 4  
1 FORM 4 wk-form4_1750895010.xml 4 8514
  Complete submission text file 0001847903-25-000114.txt   10139
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS CAMBRIDGE X0 CB22 3FH
Business Address
HUSSAIN IQBAL J (Reporting) CIK: 0001862050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 251074801